Product List
Background
MicroRNAs (miRNAs) are molecules of non-coding RNA around 22 nucleotides long and widely distributed in animals, plants, viruses and microorganisms. They regulate post-transcriptional gene expression by interacting with the 3' untranslated region (3'UTR) of the target mRNA, and impact many aspects of cell biology, from development to differentiation to apoptosis and disease generation.
The miRNA action has two main steps:
A. Translation inhibition: when the miRNA is not fully complementary to the target mRNA, the miRNA binds to the 3'UTR region of the target mRNA, thus preventing the ribosome from recognizing and binding to the target mRNA, leading to inhibition of protein translation. This mechanism is more common in mammals.
B. mRNA degradation: When the miRNA is perfectly or nearly perfectly complementary to the target mRNA, then the miRNA cleaves the target mRNA via RISC (RNA-induced silencing complex) cleavage, and the target mRNA will then be degraded. This usually happens because the AGO2 protein is an endonuclease that breaks down the target mRNA.
Figure 1. miRNA biosynthesis and its mechanism of action[1].
It is multistep in how miRNAs are produced: primary miRNAs (pri-miRNAs) are first transcribed by RNA polymerase II, broken down into precursor miRNAs (pre-miRNAs) by the enzyme Droshazyme, and finally broken down again by the enzyme Dicer to produce a mature, double-stranded miRNA. Lastly, the mature miRNAs bind to the Argonaute protein and form an RNA-induced silencing complex (RISC) that then silences the target mRNA.
MiRNAs work by cleaving complementary sequences to messenger RNA (mRNA), inhibiting translation, or breaking down mRNA. This accurate process allows gene networks responsible for growth, development, and disease to be precisely tuned.
MiRNAs are crucial in developmental biology to ensure correct tissue patterning and cell fate decisions. MiRNA expression deregulation is associated with cancer, cardiovascular disease, and neurodegenerative diseases – the most common targets for therapeutic intervention.
It is also a sign of the evolutionary importance of miRNA sequences being conserved. This universality allows cross-species research, making our observations about basic biological processes more useful.
Figure 1. miRNA-based anticancer therapeutic strategies[1].
Alfa Chemistry provides therapeutic miRNA development. We are your miRNA research and applications partner. From basic discovery to drug discovery, our services allow scientists to take advantage of miRNA biology.
And no matter where you are at in miRNA evolution, we can help.
References
Catalog | Name | Inquiry |
---|---|---|
ONT1848266716 | Remlarsen | Inquiry |
ONT2615098650 | Eldocasiran | Inquiry |
ONT0366 | MicroRNA mimic negative control | Inquiry |
ONT0367 | MicroRNA antagomir negative control | Inquiry |
ONT0368 | MicroRNA inhibitor negative control | Inquiry |
ONT0369 | microRNA Agomir negative control | Inquiry |
ONT0370 | Eldocasiran sodium | Inquiry |
ONT0371 | hsa-miR-146a-5p agomir | Inquiry |
ONT0372 | hsa-miR-155-5p mimic | Inquiry |
ONT0373 | hsa-miR-21-5p mimic | Inquiry |
ONT0374 | hsa-miR-26b-5p mimic | Inquiry |
ONT0375 | hsa-miR-29a-3p inhibitor | Inquiry |
ONT0376 | hsa-miR-138-5p agomir | Inquiry |
ONT0377 | hsa-miR-23a-3p antagomir | Inquiry |
ONT0378 | hsa-miR-127-3p inhibitor | Inquiry |
ONT0379 | hsa-miR-127-3p mimic | Inquiry |
ONT0380 | mmu-miR-326-3p agomir | Inquiry |
ONT0381 | mmu-miR-511-3p inhibitor | Inquiry |
ONT0382 | hsa-miR-100-5p mimic | Inquiry |
ONT0383 | hsa-miR-17-5p mimic | Inquiry |
Our products and services are for research use only and cannot be used for any clinical purposes.